A new study at the University of Miami's Sylvester Comprehensive Cancer Center shows the potential of personalized medicine to guide therapy in early-stage, invasive breast cancer. The study in the rapidly advancing field of molecular subtyping was led by Stefan Gluck, M.D., Ph.D., professor of medicine...
More...